The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Updated Diagnostic Criteria and Staging System for Multiple Myeloma
Abstract
There has been remarkable progress made in the diagnosis and treatment of multiple myeloma (MM). The median survival of the disease has doubled as a result of several new active drugs. These advances have necessitated a revision of the disease definition and staging of MM. Until recently, MM was defined by the presence of end-organ damage, specifically hypercalcemia, renal failure, anemia, and bone lesions (CRAB features) that can be attributed to the clonal process. In 2014, the International Myeloma Working Group (IMWG) updated the diagnostic criteria for MM to add three specific biomarkers that can be used to diagnose the disease in patients who did not have CRAB features: clonal bone marrow plasma cells greater than or equal to 60%, serum free light chain (FLC) ratio greater than or equal to 100 provided involved FLC level is 100 mg/L or higher, or more than one focal lesion on MRI. In addition, the definition was revised to allow CT and PET-CT to diagnose MM bone disease. These changes enable early diagnosis and allow the initiation of effective therapy to prevent the development of end-organ damage for patients who are at the highest risk. A new staging system has been developed that incorporates high-risk cytogenetic abnormalities in addition to standard laboratory markers of prognosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The 5 year survival rates among the patients with Stage I, II, and III RISS were 82%, 62%, and 40%, respectively [20].”
From Epidemiology, Staging, and Management of Multiple Myeloma (2021) · cites this paper as [20]
In the citing paper
“In an international clinical trial with 3060 participants, for those with stage I disease, overall survival (OS) and progression-free survival (PFS) at five years was 82% and 55%, respectively. Median PFS was 66 months, and OS was not reached.”
From Epidemiology, Staging, and Management of Multiple Myeloma (2021) · cites this paper as [20]
In the citing paper
“For Stage III disease, these values were 40%, 24%—29 months and 43 months, respectively.”
From Epidemiology, Staging, and Management of Multiple Myeloma (2021) · cites this paper as [20]
In the citing paper
“For Stage II disease, these values were 62% and 36%, 42 months and 83 months, respectively.”
From Epidemiology, Staging, and Management of Multiple Myeloma (2021) · cites this paper as [20]
In the citing paper
“Both the ISS and DSS systems assess the tumor burden, but neither ISS nor DSS takes into consideration the biology of the disease, which determines the overall survival [20,21,22].”
From Epidemiology, Staging, and Management of Multiple Myeloma (2021) · cites this paper as [20]
In the citing paper
“The revised ISS adds prognostic information such as lactate dehydrogenase (LDH) levels and chromosomal abnormalities detected via FISH.”
From Epidemiology, Staging, and Management of Multiple Myeloma (2021) · cites this paper as [20]
Citations
Cites
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationInternational Staging System for Multiple Myeloma
Greipp, P. R., Miguel, J. S., Durie, B. G. M., Crowley, J. J., Barlogie, B., Bladé, J., Boccadoro, M., Child, J. A., Avet-Loiseau, H., Kyle, R. A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.242 · Cited by 2,974
The International Myeloma Working Group (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04355.x · Cited by 2,367
Palumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Self-citationA Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance
Kyle, R. A., Therneau, T. M., Rajkumar, S. V., Offord, J. R., Larson, D. R., Plevak, M. F., & Melton, L. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa01133202 · Cited by 1,475
Self-citationLenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Mateos, M.-V., Hernández, M.-T., Giraldo, P., de la Rubia, J., de Arriba, F., Corral, L. L., Rosiñol, L., Paiva, B., Palomera, L., Bargay, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300439 · Cited by 1,171
Landgren, O., Kyle, R. A., Pfeiffer, R. M., Katzmann, J. A., Caporaso, N. E., Hayes, R. B., Dispenzieri, A., Kumar, S., Clark, R. J., Baris, D., et al. (2009) · Blood · doi:10.1182/blood-2008-12-194241 · Cited by 1,127
Self-citationClinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
Kyle, R. A., Remstein, E. D., Therneau, T. M., Dispenzieri, A., Kurtin, P. J., Hodnefield, J. M., Larson, D. R., Plevak, M. F., Jelinek, D. F., Fonseca, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070389 · Cited by 921
Self-citationKumar, S. K., Mikhael, J. R., Buadi, F. K., Dingli, D., Dispenzieri, A., Fonseca, R., Gertz, M. A., Greipp, P. R., Hayman, S. R., Kyle, R. A., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0603 · Cited by 628
Self-citationA monoclonal gammopathy precedes multiple myeloma in most patients
Weiss, B. M., Abadie, J. M., Verma, P. S., Howard, R. S., & Kuehl, W. M. (2009) · Blood · doi:10.1182/blood-2008-12-195008 · Cited by 568
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 348
Solitary plasmacytoma with amyloid – An unusual dural-based lesion
Gajaria, P., Shenoy, A. S., Chaudhari, J. P., & Goel, N. (2020) · Asian Journal of Neurosurgery · doi:10.4103/ajns.ajns_184_20 · Cited by 2
Gebreslassie, K. S., Bassa, F., Chapanduka, Z. C., & Warwick, J. (2021) · South African Journal of Oncology · doi:10.4102/sajo.v6i0.197 · Cited by 2
Paes, R. D., da Costa, D. C. R., Viana, J. F., & Watanabe, H. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-98596-7_3 · Cited by 2
Ščudla, V., Minařík, J., Pika, T., & Bačovský, J. (2017) · Interní medicína pro praxi · doi:10.36290/int.2017.060 · Cited by 2
Liu, K., Yin, Y., Zhou, X., Zhu, K., & Luo, Z. (2021) · PubMed Central · Cited by 2
Non-odontogenic Bone Pathology
Coleman, H. G., Hille, J. J., van Heerden, W. F. P., Boy, S. C., & Mahar, A. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-72303-7_23 · Cited by 2
Swan, D., Henderson, R. B., McEllistrim, C., Naicker, S. D., Quinn, J., Cahill, M. R., Mykytiv, V., Lenihan, E., Mulvaney, E., Nolan, M., et al. (2022) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2022.07.011 · Cited by 2
Chiu, L., Kuo, C.-Y., Ma, M., Liao, C., Liu, H.-L., & Wang, M. (2023) · Journal of Cancer Research and Practice · doi:10.4103/ejcrp.ejcrp-d-22-00032 · Cited by 2
Diagnosis of Amyloidosis: From History to Current Tools
Juneja, R., Dange, P., & Arora, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102006 · Cited by 1
Kavgacı, G., Köksal, B., Arık, Z., Barışta, İ., & Akın, S. (2024) · Plasmatology · doi:10.1177/26348535241277632 · Cited by 1
Quach, P., Lack, M., Ash, R. M., Cunningham, M. T., & Farrell, D. (2024) · Cureus · doi:10.7759/cureus.75336 · Cited by 1
Alhayek, B., Malone, X., Khan, A., Gummalla, R., & Brink, R. (2025) · Cureus · doi:10.7759/cureus.85455 · Cited by 1
Zhang, T., Cheng, X., Jin, Y., Zhang, R., Shen, X., Chen, L., & Shi, Q. (2025) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2025.2604564 · Cited by 1
Chumnumsiriwath, P., Bellman, P., Tran, M., Golly, C., Ciurea, S. O., & Kongtim, P. (2026) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2026.01.004 · Cited by 1
Imaging features of immune-mediated genitourinary disease
Weber, J., Hammond, N., Yaghmai, V., Nikolaidis, P., Miller, F. H., & Horowitz, J. M. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-01946-z · Cited by 1
Smouldering Myeloma: Chasing a Hyperviscous Sample
Birdi, A., Sinha, A., Banerjee, M., & SelviN, M. K. (2021) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-021-00990-1 · Cited by 1
Zhu, G., Fu, X., Ren, Y., Wang, Y., Wang, S., & An, G. (2022) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13790 · Cited by 1
Çevik, K., Mustafa Ertan, A. Y., AY, Ö. İ., TOMBAK, A., YILDIRIM, D. D., KABASAKAL, T., & ERDAL, M. E. (2023) · Indian Journal of Experimental Biology · doi:10.56042/ijeb.v61i12.2999 · Cited by 1
Gogoi, G., Dutta, N., Sonowal, S., Rajkonwar, A., Dehingia, B., Saikia, S., & Borgohain, S. (2023) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v14i12.58487 · Cited by 1
Enfermedad Renal Crónica como primera manifestación de Mieloma Múltiple a propósito de un caso
Lituma-Jumbo, R. D. L., Criollo-Ulloa, E. P., & López-Galarza, T. E. (2024) · MQRInvestigar · doi:10.56048/mqr20225.8.1.2024.590-606 · Cited by 1
Klank, D., Löffler, C., Friedrich, J., Hoffmann, M. F., Paschka, P., & Bergner, R. (2024) · Biomedicines · doi:10.3390/biomedicines12051032 · Cited by 1
Griffiths, M., Cheng, P. L., Wang, X. Y., Schneider, R. J., & Kulasingam, V. (2024) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae065 · Cited by 1
Construction of a machine learning-based screening model for IgD myeloma
Zhou, M., & Feng, S. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120488 · Cited by 1
Sharma, N. S., Nataraj, K. S., & Choudhary, B. (2025) · Medical Oncology · doi:10.1007/s12032-025-03032-5 · Cited by 1
Bellofiore, C., Basset, M., Nuvolone, M., Nanci, M., Sanna, G. D., Simone, V., Fogliani, A., Cecca, M. D., Mussinelli, R., Foli, A., et al. (2026) · HemaSphere · doi:10.1002/hem3.70320 · Cited by 1
Rudžianskienė, M., Inčiūra, A., Gerbutavičius, R., Rudžianskas, V., Ugenskienė, R., Paukštaitienė, R., Dambrauskienė, R., Vaitiekus, D., Kulbokė, M., & Juozaitytė, E. (2026) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2025-0013 · Cited by 1
Iftikhar, R., Ghani, D. A., Sarwar, S., Ali, N., Anwar, N., Bokhari, S. W., Humayun, S., Iftikhar, A., Moosajee, M., Zaidi, U., et al. (2026) · Blood Global Hematology · doi:10.1016/j.bglo.2026.100121 · Cited by 1
Paolini, L., Noto, G. D., Zendrini, A., Bergese, P., & Ricotta, D. (2017) · InTech eBooks · doi:10.5772/intechopen.69398 · Cited by 1
Oral manifestation of multiple myeloma: a case report
Tenório, J. R., Milani, B. D. A., & Matuck, B. F. (2021) · Clinical and Laboratorial Research in Dentistry · doi:10.11606/issn.2357-8041.clrd.2021.180062 · Cited by 1
Aghakhanyan, G., Sollini, M., Galimberti, S., Zanca, R., Bachi, C., Bartoli, F., & Erba, P. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-28524-0_20 · Cited by 2
Skin reaction due to intravenous bortezomib in a multiple myeloma patient
Özlü, C., Yalçın, N., Gönderen, A., & Keskin, D. (2021) · Demiroglu Science University Florence Nightingale Journal of Medicine · doi:10.5606/fng.btd.2021.54 · Cited by 1
Tskhvarashvili, G. (2024) · International Journal of Clinical and Experimental Medicine · doi:10.62347/ifuw3775 · Cited by 1
Sathya, P., Kayal, S., Hamide, A., & Kar, R. (2024) · Cureus · doi:10.7759/cureus.61504 · Cited by 1
Bilateral myelomatous pleural effusions: an unusual presentation in newly diagnosed multiple myeloma
Proskuriakova, E., Adams, M., Reddy, V. K., & Kassem, M. (2024) · BMJ Case Reports · doi:10.1136/bcr-2023-258935 · Cited by 1
New PET Tracers for Symptomatic Myeloma
Sagar, S., Khan, D., Velliangiri, S. K., & Kumar, R. (2024) · PET Clinics · doi:10.1016/j.cpet.2024.06.001 · Cited by 1
Laryngeal plasmacytoma in a patient with Down s syndrome
Hodroj, H., Saker, Z., Najjar, Z. A., Choukr, H., & Moussaoui, M. R. N. E. (2024) · Autopsy and Case Reports · doi:10.4322/acr.2024.508 · Cited by 1
An unusual presentation of multiple myeloma
Schembri, E. L., Mifsud, S., Gauci, J., Mizzi, A., & Fsadni, P. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-226412 · Cited by 1
Liquid Biopsies in Multiple Myeloma
Vrábel, D., Souckova, A., Sedlaříková, L., & Ševčíková, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.78630 · Cited by 2
Hybrid Imaging and Radionuclide Therapy in Hemato-oncology
Erba, P. A., Sollini, M., Boni, R., & Galimberti, S. (2019) · Springer eBooks · doi:10.1007/978-3-319-95564-3_26 · Cited by 1
Nonneoplastic Diseases of the Kidney
Amin, S., & Bonsib, S. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-54941-7.00001-3 · Cited by 1
Acute Kidney Injury in a Patient With Monoclonal Gammopathy
Luong, J., Andeen, N. K., Rope, R. W., Silbermann, R. W., Khalighi, M. A., & Avasare, R. S. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.05.033 · Cited by 1
Rizzello, I., Cavo, M., Dozza, L., Rivolti, E., Petrucci, M. T., Stefano, V. D., Antonioli, E., Tosi, P., D’Agostino, M., Morè, S., et al. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1897805 · Cited by 1
Hung, D., Lenton, D. S., Eslick, R., Blennerhassett, R. C., Joshi, M., McCaughan, G. J. B., Day, S., & Wright, D. C. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22975 · Cited by 1
Goldsmith, S. R., & Stockerl-Goldstein, K. E. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.01.009 · Cited by 1
Stavern, G. P. V., Smith, L. D., & James, H. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_308 · Cited by 1
Rogić, D., Barišić, K., Matišić, D., & Šegulja, D. (2022) · Biochemia Medica · doi:10.11613/bm.2022.030703 · Cited by 1
Tetraplegic spinal cord injury as a presentation of multiple myeloma: A case report
Smith, L., Li, V. Y., & Chan, S. (2023) · Clinical Case Reports · doi:10.1002/ccr3.7667 · Cited by 1
A Case Report of Plasmacytoma in a 28-Year-Old Patient: Bridging the Age Gap in a Rare Presentation
Tency, N. K., Camarena, J. A., Roy, A., & Pradeep, M. (2023) · Cureus · doi:10.7759/cureus.47671 · Cited by 1
Shokripour, M., Hosseini, S. E., Omidifar, N., Mokhtari, M., & Safaei, A. (2024) · PubMed Central · doi:10.30476/ijms.2023.96892.2855 · Cited by 1
Xu, J., Wang, M., Shen, Y., Yan, M., Xie, W., Wang, B., Song, Z., Liu, H., & Cen, X. (2020) · Research Square · doi:10.21203/rs.3.rs-88885/v1 · Cited by 1
Supportive Care in Multiple Myeloma
Doshi, S., Noff, T. T., & Roodman, G. D. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_31
Non-Odontogenic Bone Pathology
Coleman, H. G., Hille, J. J., van Heerden, W. F. P., Boy, S. C., & Mahar, A. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-28100-1_23-1
High-dose chemotherapy and autotransplants for plasma cell myeloma in Jordan
Halahleh, K., Ma’koseh, M., Abu‐Jazar, H., Yaser, S., Howar, H., AL-Rawashdeh, M., Tbakhi, A., Najjar, R., Hussein, N., Al-Rimawi, D., et al. (2018) · Bone Marrow Transplantation · doi:10.1038/s41409-018-0201-x
MIELOMA MÚLTIPLO: UMA NOVA ÓTICA SOB A ABORDAGEM DIAGNÓSTICA- RELATO DE CASO
de Oliveira, T. W. (2018) · Revista de Saúde · doi:10.21727/rs.v9i2.1313
Cardoso, F., Marques, J., da Costa, B. M., Góis, M. V., Sousa, H., & Nolasco, F. E. B. (2019) · Portuguese Journal of Nephrology & Hypertension · doi:10.32932/pjnh.2019.04.013
Role of Standard Magnetic Resonance Imaging
Salizzoni, E., Conficoni, A., & Coe, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-19019-4_4
Early Intervention in Smoldering Myeloma
Kumar, S. K. (2019) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2019.15.1.14
Morfología e inmunofenotipo de las células plasmáticas en el mieloma múltiple
Vásquez, N. J. R., Arbeláez, P. E. J., & Llanos-Albornoz, C. M. (2017) · Medicina y Laboratorio · doi:10.36384/01232576.22
Detection of M-Protein in Acetonitrile Precipitates of Serum using MALDI-TOF Mass SpectrometryPreprint
Mehra, N., Gopisetty, G., Jayavelu, S., Arivazhagan, R., Sundersingh, S., Karunakaran, P., Kalaiyarasi, J. P., Kannan, K., Radhakrishnan, V. S., Sagar, T. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.13.990192
The Role of Gremlin1 in Multiple Myeloma
Clark, K. C. (2020) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Cytodiagnosis of scalp swelling: An uncommon presentation of a common neoplasm
Rakheja, G., Agrawal, N., Handa, U., & Palta, A. (2020) · CytoJournal · doi:10.25259/cytojournal_71_2019
Belchos, M., Kumar, V., & Weis, C. A. (2020) · Europe PMC (PubMed Central)
Multiple Myeloma and Vasculitic Neuropathy: An Unusual Presentation
Simkhada, N., Adhikari, P., Baral, N., Dhakal, B., & Mahat, K. (2021) · Cureus · doi:10.7759/cureus.13776
Case series of complex therapy of hemoblastosis in the context of COVID-19
Saparbay, J., Kemaykin, V., Vildanova, R., Karabekov, A. B., & Burkitabayev, Z. (2021) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/jcmk/9735
Memon, W., Popli, K., Akram, A., Bobba, S., & Muthusamy, S. (2021) · Cureus · doi:10.7759/cureus.14461
Plasma Cell Myeloma and Related Disorders
Tute, R. M. D., Rawstron, A. C., & Owen, R. G. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316218549.009
Compromiso renal en gammapatías monoclonales
Moreno, J. A. I., González, J. M. B., Taborda-Murillo, A., Ospina, S., & Arias, L. F. (2021) · Revista Española de Patología · doi:10.1016/j.patol.2021.06.002
Kumar, S. (2020) · Journal of Advanced Research in Medicine · doi:10.24321/2349.7181.202019
Ebian, H. F., Abdelwahab, M., Elbasateeny, S. S., Abdelmoneem, S., & Elrahman, H. E. A. (2021) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2021.195418
(2018) · Elsevier eBooks · doi:10.1016/b978-0-323-39254-9.50157-4
A Fast-Growing Tumor on the Head of an Elderly Woman: Answer
Benavent, M. P., González-Delgado, V. A., Adrián, J. C. G., Félix, F. R., & Martínez‐Ciarpaglini, C. (2022) · American Journal of Dermatopathology · doi:10.1097/dad.0000000000002153
Yassin, A. K., Khsohnaw, N. S. H., Jalal, S. D., Mohammed, A. M., Hasan, K. M., Abdulla, D. A., Badi, A., Safar, B. M., Abdulla, B. K., Shamoon, R. P., et al. (2022) · Advanced medical journal · doi:10.56056/amj.2022.147
Diagnostic Applications of Nuclear Medicine: Multiple Myeloma
Aghakhanyan, G., Sollini, M., Galimberti, S., Zanca, R., Boni, R., Esposito, E., Bartoli, F., & Erba, P. A. (2022) · Springer eBooks · doi:10.1007/978-3-319-26067-9_8-3
Govind, U., & Philip, F. K. (2022) · National Journal of Laboratory Medicine · doi:10.7860/njlm/2022/53145.2601
Kardiale Amyloidose – wichtige Differenzialdiagnose bei Herzinsuffizienz
Morbach, C., Steinhardt, M., & Störk, S. (2022) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1810-9199
Miscellaneous Etiologies of Acute Kidney Injury
Joy, C. M., & Vijayan, A. (2022) · Wiley eBooks · doi:10.1002/9781119105954.ch12
Diagnostic Applications of Nuclear Medicine: Multiple Myeloma
Aghakhanyan, G., Sollini, M., Galimberti, S., Zanca, R., Boni, R., Esposito, E., Bartoli, F., & Erba, P. A. (2022) · Springer eBooks · doi:10.1007/978-3-031-05494-5_8
Plasma Cell Myeloma dengan Temuan Histopatologi pada Tulang Humerus
Yona, F. (2022) · Health & Medical Journal · doi:10.33854/heme.v4i2.982
Case 24: Active Myeloma Versus Schmorl’s Node
Wong, C. Y. O., & Wu, D. (2022) · Springer eBooks · doi:10.1007/978-3-031-09737-9_24
Multiple waxy papules in a woman in her fifties
Mustari, A. P., Parkhi, M., & Vinay, K. (2023) · Clinical and Experimental Dermatology · doi:10.1093/ced/llad027
Multiple Myeloma in the Era of Novel Agents and Stem Cell Therapies
Al‐Anazi, K. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.109279
An Unusual Presentation of Extramedullary Plasmacytoma in the Orbit in a Middle-Aged Woman
Ameen Sumais, A. P., Santhosh Kumar, N., Hameed, S., Thanzeer, N. T. K., Manoharan, S., & Warrier, N. E. (2023) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-023-03749-7
Atypical Multiple Myeloma Case: Atypical Clinical Presentation, in Female and at Young Age
Surnar, S., Tare, K. H., Bhosikar, A. M., Desale, S., & Nasikkar, N. S. (2023) · Journal of the Association of Physicians of India · doi:10.5005/japi-11001-0194
Chest Pain Caused by Thoracic Spine Plasmacytoma: A Case Report
Gaibor, C., & Qadri, N. (2023) · Cureus · doi:10.7759/cureus.38131
An unusual presentation of paraproteinemia: Call for a new entity
Chauhan, K., Kathuria, K., & Hatwal, V. (2023) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_162_22
GAGLIARDI, A., TOBIA, F., BATTISTA, G., Bruno, F., & Masciocchi, C. (2023) · Journal of Radiological Review · doi:10.23736/s2723-9284.23.00236-7
Oral Manifestations of Malignant Immunoglobinopathy Hidden in Plain Sight - A Rare Case Report
Sharma, N. K., Singh, A. K., Hirani, M. S., Krishnan, A., Mahajan, A., & Rajpoot, R. (2023) · Annals of Maxillofacial Surgery · doi:10.4103/ams.ams_75_22
Berghe, T. V. D., Brack, D., Clercq, A. D., Dorpe, J. V., Dutoit, J. C., Vanhoenacker, F. M. H. M., & Verstraete, K. L. (2023) · Medical radiology · doi:10.1007/174_2023_452
Turgutkaya, A., YAVAŞ, İ., Şahin, T., Sargın, G., Kadıköylü, G., & Bolaman, A. Z. (2023) · Ege Tıp Dergisi · doi:10.19161/etd.1147765
Pain management in patients with multiple myeloma
Kammoun, F., Kallel, F., Charfi, M., Medhaffar, M., & Elloumi, M. (2023) · Douleurs Évaluation - Diagnostic - Traitement · doi:10.1016/j.douler.2023.11.006
Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons
Pearse, W. B., & Reid, E. G. (2024) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2026.05.023
Asymptomatic skin lesions as a diagnostic clue in multiple myeloma – A case report
Jayaprakash, A., Pappen, T. T., Sebastian, R., Kunjukunju, B. P., Joseph, A., & Mathew, L. (2024) · Journal of Skin and Sexually Transmitted Diseases · doi:10.25259/jsstd_3_2024
Nonalbumin Proteinuria in a Patient with Slowly Worsening Kidney Function
Schoonmaker, J. A., Ryan, M. S., & Bhasin-Chhabra, B. (2024) · Kidney360 · doi:10.34067/kid.0000000000000338
Shaaban, I. O. A., Sultan, H. K., Sultan, M., Gammal, M. M. A. E., & Balbaa, O. A. (2023) · The Egyptian Journal of Haematology · doi:10.4103/ejh.ejh_55_23
Røllum-Larsen, J., Engell, A. E., Diaz‐delCastillo, M., Heegaard, A., & Jørgensen, H. L. (2024) · Annals of Hematology · doi:10.1007/s00277-024-05822-9
Metadata
- Authors
- Rajkumar, S. V.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Rajkumar, S. Vincent
- ORCID
- Rajkumar, S. Vincent
- Venue
- American Society of Clinical Oncology Educational Book
- Published
- 2016-05
- Volume
- 36
- Issue
- 36
- Pages
- e418-e423
- ISSN
- 1548-8748 (ISSN-L)
- 1548-8756
- OpenAlex
- W4245689579
- Cited by
- 350
- References
- 33
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 46 · 2023: 50 · 2022: 52 · 2021: 50 · 2020: 32 · 2019: 23 · 2018: 17 · 2017: 14
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Society of Clinical Oncology Educational Book (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Health Sciences › Medicine › Hematology › Chronic Lymphocytic Leukemia Research
- Keywords
- multiple myeloma, diagnostic criteria, disease staging, serum free light chain ratio, bone lesions, high-risk cytogenetics, prognosis
- MeSH terms
- Positron Emission Tomography Computed Tomography, Bone Marrow Cells, Humans, Magnetic Resonance Imaging, Multiple Myeloma, Neoplasm Staging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
